2 - TI Pharma

More documents

Recommendations

Info

Chapter 8 Low-dose Glucocorticoid Treatment Affects Multiple Aspects of Intermediary Metabolism in Healthy Humans: a Randomized Controlled Trial D.H. van Raalte*, M. Brands*, N.J. van der Zijl, M.H. Muskiet, P. J.W. Pouwels , M.T. Ackermans, H.P. Sauerwein, M.J. Serlie and M.Diamant *Both authors contributed equally Diabetologia. 2011; 54(8):2102-12
Page 2:
Diabetogenic Effects of Glucocortic
Page 6:
VRIjE UNIVERSITEIT Diabetogenic Eff
Page 10:
Leescommissie: prof.dr. M. Boers pr
Page 14:
Chapter 12 Angiopoietine-like prote
Page 22:
Chapter 1 General Introduction and
Page 26:
Figure 1. Overview of the therapeut
Page 30:
inding to the intracellular GR, fol
Page 34:
further explored the effects of bot
Page 38:
17. Kaplan SA, Shimizu CS. Effects
Page 46:
Chapter 2 Novel Insights into Gluco
Page 50:
1. INTRoDUCTIoN Glucocorticoid (GC)
Page 54:
which GCs enhance gene transcriptio
Page 58:
after GC-treatment has been propose
Page 62:
oral), the vulnerability of the pop
Page 66:
4.2. Glucocorticoids modulate adipo
Page 70:
metabolism by reducing the expressi
Page 74:
At older age, these mice developed
Page 78:
mice with adipose tissue-specific 1
Page 82:
REFERENCES 1. McMahon M, Gerich j,
Page 86:
31. Henriksen jE, Alford F, Vaag A,
Page 90:
60. Opherk C, Tronche F, Kellendonk
Page 94:
89. Seckl jR, Morton NM, Chapman KE
Page 98:
118. Matsumoto K, Yamasaki H, Akaza
Page 106:
PART Glucocorticoids and islet-cell
Page 112:
Chapter 3 Glucocorticoids induce be
Page 116:
Page 120:
Page 124:
Page 128:
Page 132:
Page 136:
Page 140:
Page 144:
Page 152:
Chapter 4 Glucocorticoids impair be
Page 156:
Page 160:
Page 164:
Page 168:
Page 172:
Page 176:
Page 184:
Chapter 5 Glucocorticoids, islet-ce
Page 188:
Page 192:
Page 196:
Page 200:
Page 204:
Page 208:
Page 212:
Page 216:
Page 220:
Page 224:
Page 232:
Chapter 6 Glucocorticoid receptor S
Page 236:
Page 240:
Page 244:
Page 248: Chapter 6 Glucocorticoid receptor S
Page 266: Chapter 7 Glucagon-Like Peptide-1 R
Page 270: Glucocorticoids (GCs) are diabetoge
Page 274: glucagon, acetaminophen and exenati
Page 278: C-peptide (AUC CP ) tended to be lo
Page 282: Figure 2. The effect of prednisolon
Page 286: oth drugs as well as their interact
Page 290: REFERENCES 1. van Raalte DH, Ouwens
Page 294: SUPPLEMENTAL FIGURES Supplemental F
Page 304: Chapter 8 Glucocorticoids affect in
Page 350:
Chapter 9 Glycosphingolipid Metabol
Page 354:
INTRoDUCTIoN Glucocorticoids (GCs)
Page 358:
Experimental protocol: The design o
Page 362:
oxidative phosphorylation (OXPHOS)
Page 366:
Table 3. Mitochondrial respiration
Page 370:
prednisolone 30 mg group, and the c
Page 374:
REFERENCES 1. Schacke H, Docke WD,
Page 378:
29. Kabayama K, Sato T, Saito K, Lo
Page 386:
Chapter 10 Glucocorticoid Treatment
Page 390:
Glucocorticoids (GCs) represent the
Page 394:
capillary recruitment. Capillary re
Page 398:
elatively small numbers in each gro
Page 402:
Table 2. Metabolic parameters and b
Page 406:
Table 3. Capillary density before a
Page 410:
Prednisolone and insulin signaling
Page 414:
DISCUSSIoN This is the first study
Page 418:
glucose uptake suggesting that the
Page 422:
15. de jongh RT, Serne EH, RG Ij, d
Page 426:
SUPPLEMENTARy MATERIAL Supplemental
Page 434:
Chapter 11 Glucocorticoids alter Su
Page 438:
Glucocorticoids (GCs) are important
Page 442:
Adipose tissue was washed with ster
Page 446:
Figure 1. Effects of glucocorticoid
Page 450:
Impaired insulin action in adipose
Page 454:
REFERENCES 1. van Raalte DH, Ouwens
Page 458:
30. Ouchi N, Parker JL, Lugus JJ, W
Page 464:
Chapter 12 Angptl4 in glucocorticoi
Page 468:
Page 472:
Page 476:
Page 480:
Page 484:
Page 488:
Page 494:
PART Metabolic Effects of Glucocort
Page 500:
Chapter 13 Glucocorticoids in acute
Page 504:
Page 508:
Page 512:
Page 516:
Page 520:
Page 524:
Page 528:
Page 534:
Chapter 14 Glucose Tolerance, Insul
Page 538:
INTRoDUCTIoN Rheumatoid arthritis (
Page 542:
independent ethics committee approv
Page 546:
Glucose tolerance state: The preval
Page 550:
Data represent means ± standard de
Page 554:
**** Number of DMARDs (both synthet
Page 558:
Effect modification: As compared to
Page 562:
described here, may even be underes
Page 566:
15. Wolfe F, Michaud K. Corticoster
Page 574:
PART Discussion V
Page 580:
Chapter 15 General Discussion Gluco
Page 584:
Chapter 15 General Discussion Studi
Page 588:
Chapter 15 General Discussion Figur
Page 592:
Chapter 15 General Discussion AMP-a
Page 596:
Chapter 15 General Discussion shown
Page 600:
Chapter 15 General Discussion decre
Page 604:
Chapter 15 General Discussion Inter
Page 608:
Chapter 15 General Discussion Mecha
Page 612:
Chapter 15 General Discussion and a
Page 616:
Chapter 15 General Discussion and p
Page 620:
Chapter 15 General Discussion short
Page 624:
Chapter 15 General Discussion Table
Page 628:
Chapter 15 General Discussion REFER
Page 632:
Chapter 15 General Discussion 30. S
Page 636:
Chapter 15 General Discussion 58. L
Page 640:
Chapter 15 General Discussion 88. F
Page 644:
Chapter 15 General Discussion 119.
Page 648:
Page 652:
Page 658:
Nederlandse Samenvatting Diabetogen
Page 662:
het bleek ook heel effectief bij de
Page 666:
door prednisolon behandeling. In di
Page 670:
In deel 4 van mijn proefschrift bes
Page 678:
Dankwoord Acknowledgements
Page 682:
Geachte Dr. Ouwens, beste Margriet.
Page 686:
Dr. Kersten, beste Sander, veel dan
Page 694:
Biography
Page 698:
Daniël Henri van Raalte was born o
Page 704:
List of Publications 1. van Genugte
Page 708:
List of Publications 20. van Raalte
Page 716:
List of co-author affiliations Andr
Page 720:
List of co-author affiliations Jos
Page 724:
List of co-author affiliations Timo
Page 732:
Color Figures Chapter 1 Figure 1. O
show all

2 - TI Pharma

Create successful ePaper yourself

Delete template?

Save as template?